US Patent 7884181 Pharmaceutical formulation comprising crystalline insulin and dissolved insulin

Patent 7884181 was granted and assigned to Novo Nordisk on February, 2011 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

February 8, 2011

Patent Application Number

11664407

Date Filed

October 5, 2005

Patent Primary Examiner

Patent abstract

The invention provides a pharmaceutical formulation and a method for preparing the formulation.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7884181 Pharmaceutical formulation comprising crystalline insulin and dissolved insulin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.